首页> 美国卫生研究院文献>other >Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy
【2h】

Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy

机译:联合的低miRNA-29s是预测肝切除术后肝细胞癌患者预后的独立危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The prediction of prognosis of hepatocellular carcinoma (HCC) following partial hepatectomy is still an unresolved issue. The aim of this study is to identify the association between miRNA-29s family and the prognosis of patients with HCC in a large Asian cohort. We retrospectively reviewed 122 patients with HCC managed in our institution between 2008 and 2015. The expression of miRNA-29s was detected by real-time polymerase chain reaction (PCR). Prognostic factors were evaluated using Kaplan–Meier curves and Cox proportional hazards models. For the entire cohort of 122 patients, the normalized real-time PCR results showed that miRNA-29s (miR-29a, miR-29b, and miR-29c) were deregulated in tumor tissues as compared with corresponding nontumorous tissue samples. We then performed survival analysis to investigate the prognostic value of miRNA-29s. We found that low miR-29b was associated with a decreasing 5-year overall survival (OS) rate from 70.2% to 39.1% and low miR-29c was associated with a decreasing 5-year OS rate from 53.6% to 23.7%. We further conducted multivariate Cox proportional hazards analysis adding the variable of combined low miR-29b and low miR-29c. The results demonstrated that combined low miR-29b and miR-29c was an independent prognostic factor of patients with HCC. In conclusion, we found that the miRNA-29s were down-regulated in tumor tissues as compared with corresponding nontumorous tissue samples. Combined low miR-29b and miR-29c was an independent prognostic factor of patients with HCC.
机译:对部分肝切除术后肝细胞癌(HCC)预后的预测仍未解决。这项研究的目的是确定一个亚洲大队列中的miRNA-29s家族与HCC患者的预后之间的关联。我们回顾性研究了2008年至2015年间在我们机构管理的122例HCC患者。通过实时聚合酶链反应(PCR)检测miRNA-29s的表达。使用Kaplan-Meier曲线和Cox比例风险模型评估预后因素。对于122名患者的整个队列,标准化的实时PCR结果显示,与相应的非肿瘤组织样品相比,肿瘤组织中的miRNA-29s(miR-29a,miR-29b和miR-29c)被失调了。然后,我们进行了生存分析,以调查miRNA-29s的预后价值。我们发现低miR-29b与5年总生存率从70.2%降低到39.1%相关,而低miR-29c与5年总生存率从53.6%下降到23.7%相关。我们进一步进行了多变量Cox比例风险分析,增加了低miR-29b和低miR-29c的组合变量。结果表明,低miR-29b和miR-29c联合使用是肝癌患者的独立预后因素。总之,我们发现与相应的非肿瘤组织样品相比,miRNA-29s在肿瘤组织中被下调。低miR-29b和miR-29c联合使用是肝癌患者的独立预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号